News
Biotech Notebook: Treasure from cellular trash; science gets artsy at Symphony at Salk
Once disregarded as waste, exosomes now are known as important cellular messengers. Scripps Research study illuminates their role in brain health […]
Month: July 2019
News
Two therapeutic targets identified for deadly lung cancer
LA JOLLA?(July 26, 2019) The vast majority of deadly lung cancer cases (85 percent) are termed non-small-cell lung carcinomas (NSCLCs), which often contain a mutated gene called LKB1. Salk Institute researchers have now discovered precisely why inactiv… […]
News
GenMark Diagnostics to Participate in the Canaccord Genuity Growth Conference
CARLSBAD, Calif., July 25, 2019 (GLOBE NEWSWIRE) — GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the upcoming Canacc… […]
News
INmune Bio Co-Founder and CEO Presents at 17th Annual Congress of International Drug Discovery Science & Technology 2019
LA JOLLA, Calif., July 25, 2019 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient?s innate immune system to fight disease, today announced that C.J. Barnum, Director o… […]
News
SDBN BUZZ Podcast: Christina Waters – Rare Science
Christina Waters is the CEO and president of RARE Science. The mission is?to identify more immediate therapeutic solutions for kids with rare diseases. There may be 7-8000 rare diseases, but because of their rarity, they […]
News
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2019
SAN DIEGO–(BUSINESS WIRE)–ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading connected health company, today announced results for its quarter ended June 30, 2019. Fourth Quarter 2019 Highlights Revenue increased 13% to $705.0 million; up 15% on a co… […]
News
MediciNova Appoints Kazuko Matsuda to its Board of Directors
LA JOLLA, Calif., July 24, 2019 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced the appointment… […]
News
Biotech Briefing: Cradle Genomics Raises $17 Million for More Comprehensive Prenatal Tests
Reports + Research Cradle Genomics Raises $17 Million for More Comprehensive Prenatal Tests The $17.1 million Series A financing was led by Illumina Ventures and Section 32 with participation from Alexandria Real Estate Equities, Sea Lane Ventures, Lis… […]
News
Obalon Announces Second Quarter 2019 Financial Results
SAN DIEGO, July 24, 2019 (GLOBE NEWSWIRE) — Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obe… […]
News
Synthorx Initiates Patient Dosing in Australia and Announces Clearance of IND in the U.S. for Lead Immuno-oncology Product Candidate, THOR-707
SAN DIEGO, July 24, 2019 (GLOBE NEWSWIRE) — Synthorx, Inc. (NASDAQ: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, announced today it has opened HAMMER, a global, Phase 1/2, first… […]
